Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardian Pharmacy Services (GRDN) Enterprise Value (2023 - 2025)

Guardian Pharmacy Services' Enterprise Value history spans 3 years, with the latest figure at -$53.5 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 2120.95% year-over-year to -$53.5 million; the TTM value through Dec 2025 reached -$53.5 million, down 2120.95%, while the annual FY2025 figure was -$53.5 million, 2120.95% down from the prior year.
  • Enterprise Value for Q4 2025 was -$53.5 million at Guardian Pharmacy Services, down from -$24.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $30.9 million in Q4 2023 and bottomed at -$53.5 million in Q4 2025.
  • The 3-year median for Enterprise Value is -$8.7 million (2025), against an average of -$13.0 million.
  • The largest YoY upside for Enterprise Value was 19.9% in 2025 against a maximum downside of 2120.95% in 2025.
  • A 3-year view of Enterprise Value shows it stood at $30.9 million in 2023, then crashed by 91.44% to $2.6 million in 2024, then tumbled by 2120.95% to -$53.5 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Enterprise Value are -$53.5 million (Q4 2025), -$24.7 million (Q3 2025), and -$8.7 million (Q2 2025).